Home » Reports » Broker Ratings » AstraZeneca plc 9.5% Potential Upside Indicated by Kepler Cheuvreux
broker ratings

AstraZeneca plc 9.5% Potential Upside Indicated by Kepler Cheuvreux

AstraZeneca plc using EPIC/TICKER code LON:AZN has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ today by analysts at Kepler Cheuvreux. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Kepler Cheuvreux have set their target price at 5000 GBX on its stock. This now indicates the analyst believes there is a possible upside of 9.5% from today’s opening price of 4565.5 GBX. Over the last 30 and 90 trading days the company share price has decreased 287 points and increased 267.5 points respectively.

AstraZeneca plc LON:AZN has a 50 day moving average of 4,837.52 GBX and a 200 day moving average of 4,772.10 GBX. The 52 week high for the share price is currently at 5505 GBX while the 52 week low for the stock is 3680 GBX. There are currently 1,262,529,764 shares in issue with the average daily volume traded being 2,090,671. Market capitalisation for LON:AZN is £57,697,610,215 GBP.


AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience.

You might also find these articles of interest:

Register here to be notified of future articles like this
Get all our broker ratings on Twitter as they are published!